Marc Horn

Marc Horn currently serves as President of Merck China and Chief Transformation Officer for Life Science at Merck Group, roles held since December 2021. Prior to this, Marc Horn was Executive Vice President at MilliporeSigma, overseeing Life Science Controlling from August 2017 to January 2022. Earlier positions at Merck Group include Managing Director and General Manager of Merck Biopharma China and Regional Chief Financial Officer for Eastern Asia. Marc Horn also held senior financial roles at Lanxess, Bayer, and completed a Trainee position in Corporate Finance at Bayer AG. Academic qualifications include a Master of Business Administration from Otto-Friedrich-Universität Bamberg, focusing on International Management and Economics.